EMA beginnt "rolling review" für Omikron-Varianten-Impfstoffe von BioNTech

The European Medicines Agency (EMA) has started a rolling review of a variant-adapted COVID-19 vaccine from Pfizer and BioNTech , it said on Tuesday.